Surrozen, Inc. (SRZN)
Largest Insider Buys in Sector
SRZN Stock Price History Chart
SRZN Stock Performance
About Surrozen, Inc.
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody …
Insider Activity of Surrozen, Inc.
Over the last 12 months, insiders at Surrozen, Inc. have bought $6.05M and sold $0 worth of Surrozen, Inc. stock.
On average, over the past 5 years, insiders at Surrozen, Inc. have bought $3.02M and sold $3,924 worth of stock each year.
Highest buying activity among insiders over the last 12 months: COLUMN GROUP III GP, LP (10 percent owner) — $6M. Kutzkey Tim () — $3M. Parker Craig C (Chief Executive Officer) — $24,999.
The last purchase of 193,548 shares for transaction amount of $3M was made by Kutzkey Tim () on 2024‑04‑04.
List of Insider Buy and Sell Transactions, Surrozen, Inc.
| 2024-04-04 | 193,548 7.5667% | $15.50 | $3M | -12.62% | ||||
| 2024-04-04 | 10 percent owner | 193,548 7.5667% | $15.50 | $3M | -12.62% | |||
| 2024-04-04 | CFO and COO | 1,474 0.0631% | $16.96 | $24,999 | -12.62% | |||
| 2024-04-04 | Chief Executive Officer | 1,474 0.0631% | $16.96 | $24,999 | -12.62% | |||
| 2020-12-01 | director | 24,000 – | $0 | $0 | +1114.75% | |||
| 2020-12-01 | Chief Financial Officer | 24,000 – | $0 | $0 | +1114.75% | |||
| 2020-12-01 | director | 24,000 – | $0 | $0 | +1114.75% | |||
| 2020-12-01 | director | 24,000 – | $0 | $0 | +1114.75% | |||
| 2020-11-23 | director | 1M – | $0 | $0 | +1115.00% | |||
| 2020-11-23 | director | 410,000 – | $0 | $0 | +1115.00% | |||
| 2020-11-23 | Chief Financial Officer | 410,000 – | $0 | $0 | +1115.00% | |||
| 2020-11-23 | director | 410,000 – | $0 | $0 | +1115.00% | |||
| 2020-11-23 | director | 410,000 – | $0 | $0 | +1115.00% | |||
| 2020-11-18 | Sale | director | 90,000 0.0025% | $0.01 | $981 | +1115.66% | ||
| 2020-11-18 | Sale | Chief Financial Officer | 90,000 0.0025% | $0.01 | $981 | +1115.66% | ||
| 2020-11-18 | Sale | director | 90,000 0.0025% | $0.01 | $981 | +1115.66% | ||
| 2020-11-18 | Sale | director | 90,000 0.0025% | $0.01 | $981 | +1115.66% |